The formation of oxygen-containing heterocycles via intramolecular cyclizations of halo-substituted acylsilanes and unsaturated acylsilanes

DOI: 10.1016/S0040-4020(99)00936-9

Source and publish data:

Tetrahedron p. 14587 - 14598 (1999)

Update date:2022-08-03

Topics:

Authors:

Tsai, Yeun-Min

Cherng, Chaur-Donp

Nieh, Hong-Chang

Sieh, Jiuen-Ahn

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4020(99)00936-9

Halo-substituted acylsilanes undergo cyclizations easily when heated in a polar solvent such as NMP to afford 2-silyldihydrofurans and 2- silyldihydropyrans. Unsaturated acylsilanes undergo cyclizations through reactions with iodine, phenylselenenyl bromi

Full text of DOI:10.1016/S0040-4020(99)00936-9

Products guided by the article

Product name:6-methyldiphenylsilyl-2-phenylselenenylmethyl-3,4-dihydro-2H-pyran

Cas No:256506-29-3

R&D Labs maybe for 256506-29-3

Sichuan JieYao Co., Ltd.

Contact:+86-838-5655598

Address:Guanghan Nanfeng Industrial Zone
A-Chem Technologies Co.,Ltd.

Contact:+86-512-69561895

Address:No.111, Building A4, 218 Xinghu Street, Suzhou Industrial Park, P. R. China
Yangzhou Zhongbao Pharmaceutical Co.,Ltd

Contact:+86-514-88290838

Address:Jiangsu Baoying county economic develpment zone in baoying avenue91
WUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.

Contact:13861062998

Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Chengdu Chengnuo New-Tech Co., Ltd

Contact:0086-028-85749078

Address:4 Jiuyang road,Jiulong industrial port,Chengdu, China

Relevant to this article

Doi:10.1016/S0040-4039(01)87573-0
(1970)
Total synthesis of 5-N-acetylardeemin and amauromine: Practical routes to potential MDR reversal agents

Doi:10.1021/ja991558d
(1999)
The first asymmetric syntheses of L-homocysteine and L-homocystine

Doi:10.1016/S0957-4166(99)00453-X
(1999)
Doi:10.1039/j39700000583
(1970)
Doi:10.1039/j39690002425
(1969)
On peptide syntheses. 33.3. On angiotensin analogues. Synthesis of lys-6-val-5-, of tyr-3-val-5-, of tyr(Me)-4-val-5- and of tyr-8-val-5-angiotensin II-asp-l-beta amide

Doi:10.1002/jlac.19656840129
(1965)

Article Doi